SCG Cell Therapy GmbH

SCG Cell Therapy is a clinical-stage biotech company focusing on the development of novel immunotherapies for patients with pathogenic infections and its associated cancers. 
SCG stands for S-Singapore, C-China, G-Germany. Our name reflects who we are as an international team located at sites in Singapore, Shanghai and Munich. Our mission is to design and develop novel immunotherapies for patients by combining the regional strengths of each site and translating state of the art scientific and clinical advances to fulfil unmet medical needs.  Our aim is to harness the patient's immune system to target pathogenic infections or related antigens to prevent and treat cancer.